Expanding kidney paired donation through participation by compatible pairs

Am J Transplant. 2007 Oct;7(10):2361-70. doi: 10.1111/j.1600-6143.2007.01935.x.


In kidney paired donation (KPD), incompatible pairs exchange kidneys so that each recipient receives a compatible organ. This modality is underutilized partly because of the difficulty of finding a suitable match among incompatible pairs. Alternatively, recipients with compatible donors might enter KPD arrangements in order to be matched with a donor predicted to give greater allograft durability or for other altruistic reasons. Using simulated donors and recipients, we investigated the impact of allowing recipients and their compatible donors to participate in KPD. For KPD programs of any size, the participation of compatible donor/recipient pairs nearly doubled the match rate for incompatible pairs (28.2% to 64.5% for single-center program, 37.4% to 75.4% for national program). Legal, logistical, and governmental controversies have hampered the expansion of KPD in the United States by delaying the creation of a national program. The inclusion of compatible pairs into small single-center pools could achieve match rates that would surpass that which could be realized by a national list made up of only incompatible pairs. This new paradigm of KPD can immediately be instituted at the single-center level, while the greatest gains will be achieved by incorporating compatible pairs into a national program.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Acute Disease
  • Adult
  • Child
  • Cohort Studies
  • Female
  • Graft Rejection / immunology
  • Histocompatibility Testing
  • Humans
  • Isoantibodies / blood
  • Kidney Transplantation / immunology
  • Kidney Transplantation / mortality
  • Kidney Transplantation / physiology*
  • Kidney Transplantation / statistics & numerical data*
  • Kidney*
  • Living Donors / statistics & numerical data
  • Male
  • Middle Aged
  • Mothers
  • Retrospective Studies
  • Survival Analysis
  • Tissue Donors / statistics & numerical data*


  • Isoantibodies